Heidelberg AppWay

Heidelberg AppWay – Your secure way to ophthalmic apps

Heidelberg AppWay is a secure gateway to access both clinical and research applications that can offer additional insight into diagnostic images from Heidelberg Engineering and third-party devices.

Utilizing cloud exchange technology, this novel workflow solution allows you to choose from multiple SaaS (software as a service) providers within your image management platform HEYEX 2.

Access to AI Analytics: Secure. Simple. Seamless

With the rapid development and market introduction of deep learning algorithms for decision guidance and diagnostic insight, Heidelberg AppWay offers a compliant and secure workflow to combine the power of Heidelberg Engineering image quality and analytical or artificial intelligence applications for clinical routine and scientific research.

Experience the workflow

Choose your app for additional clinical insight

Heidelberg Engineering has partnered with SaaS and AI companies to provide secure access to innovative ophthalmic apps. Get to know the app partners:

We have enhanced both fluid and GA monitoring through a partnership with RetInSight, a global pioneer in AI-based retinal image analysis and provider of reading center services. Through HEYEX 2 with Heidelberg AppWay, users can easily access RetInSight’s CE-certified GA Monitor and Fluid Monitor to improve patient outcomes and clinical efficiency.

GA Monitor is the first and only MDR CE-certified AI-based OCT imaging solution for identifying disease activity and therapeutic response in geographic atrophy in clinical routine. Making the invisible visible, by visualizing and quantifying PR degeneration and RPE loss.

Quantify and visualize fluid dynamics in nAMD with Fluid Monitor, an AI-based and MDR CE-certified medical OCT imaging software solution for clinical routine. Move from subjective to objective evaluation.

“RetInSight and Heidelberg Engineering share a strong common goal: Improving patient care by providing efficient and highly precise AI-powered software solutions for OCT imaging in clinical routine, clinical studies and research.” Said Corinna zur Bonsen-Thomas, CEO of RetInSight.

Further Apps

Reflectivity for HEYEX 2 offers a revolutionary glaucoma care tool, delivering detailed 3D optic nerve analysis and a solid risk assessment in an easy-to-interpret patient report, promising to significantly improve glaucoma management.

Now the CE-marked Altris AI OCT scan analysis that detects 70+ biomarkers and retinal pathologies, including early glaucoma is available through HEYEX 2 with Heidelberg AppWay. Automated quantitative analysis of biomarkers and disease progression make treatment results monitoring more efficient for eye care specialists.

deepeye® TPS is the first CE-marked predictive AI assistant for IVI therapy planning in nAMD, integrated with HEYEX 2 via Heidelberg AppWay.
Designed to improve efficiency and effectiveness, its workflow is seamless: medical assistants send SD-OCT scans with just 1–2 clicks. The AI then analyzes the pseudonymized scans and generates a report including:

Assessment of disease activity for one-glance therapy decision support
Biomarker visualization for explainability of AI recommendation
12-month therapy need prognosis to support patient education
Trend diagrams on therapy progress
Text summary for accelerated documentation
Try their solution for free by clicking here

The new dream team of doctor and AI assistant has the potential to optimise treatment strategies and improve patient outcomes, and thereby also the financial stability of clinics.

We recently partnered with Eye2Gene™, a groundbreaking research project of the University College London Institute of Ophthalmology funded by the National Institute for Health and Care Research (NIHR) and Moorfields Eye Charity, to develop a groundbreaking AI-based software to accelerate the genetic diagnosis of inherited retinal diseases, based on SPECTRALIS imaging and available through HEYEX 2 with Heidelberg Appway.

The project focuses on inherited retinal diseases and aims to provide clinicians with in-depth genetic insights: By analyzing retinal scans, clinicians may be able to identify the specific gene responsible for the inherited condition, leading to a more accurate diagnosis and personalized treatment for patients.

The GA Grader is an innovative tool that provides accurate AI-based automated analysis of geographic atrophy lesion size based on analysis of OCT imaging data natively integrated with HEYEX 2 with Heidelberg AppWay, developed by the AMD experts at the GRADE Reading Center. Longitudinal documentation with a graphical gradient plot greatly facilitates monitoring of natural history and opens the door for potential evaluation of treatment response.

Through HEYEX 2 with Heidelberg AppWay, we offer access to AI-based apps developed by RetinAI Medical AG, a Swiss company specialized in software solutions that accelerate clinical, research and pharmaceutical workflows, with a focus on retinal diseases.

RetinAI’s disease evaluation apps consist of a set of CE-marked AI models approved for clinical and research use only. These models include fluid and layer segmentation, macular biomarker detection, and GA progression prediction to support your diagnosis and research on nAMD, dAMD, DR/DME, CME & GA.